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Background: GDM is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy. Pregnancy causes some insulin resistance in all women, but only a few develop GDM. Objective: To test the hypothesis that women 
with GDM have impaired regulation of blood iron storage and transport, decreased renal function 
due to decreased glomerular filtration rate and occurrence of urinary tract infection (UTI). Study 
design and Methods: Incidence of blood iron storage was investigated in n=30 pregnant kosovar 
women with GDM after mild of pregnancy and in n=30 pregnant women without GDM (years 2010-
2012). Results and Discussion: Baby weights, both systolic and diastolic BP, creatinine, albumin, 
lymphocytes, monocytes, WBC and granulocytes in both groups were within their normal ranges 
in both groups. Compared to control group, glucose was higher in women with GDM (mean ± SD: 
7.43±2.23 mg/dL vs. 4.33±0.63 mg/dL; P<0.001). Women with GDM had also higher RBC (mean 
± SD: 4.4±0.8 % vs. 3.8 ± 0.3 %; P<0.005) and HGB (mean ± SD: 13.0±3.2 g/dL vs. 11.2±1.4 mg/dL; 
P<0.05), and decreased renal functionality (MDRD-GFR: 92.8 ± 25.8 g/dL vs. 108.2 ± 38.2 g/dL; 
P<.05).Conclusion: There is a potential association between iron status and GDM. The role of iron 
from diet and/or from supplementation in GDM pathogenesis needs still to be examined. In addition 
we have observed a decrease of glomerular filtration rate in women with GDM. Due to the lack of 
studies on the relationships between GDM and UTI, and to the retrospective design of the present 
investigation, it is difficult to establish whether UTI may be a GDM causal factor or a consequence 
of GDM symptoms, signs and/or of its correlated pathologies. Key words: Gestational diabetes, 
preeclampsia, blood iron regulation, urinary tract infections, oxidative stress.
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1. inTroDUCTion
GDM is a condition in which pregnant 
women without previously diagnosed di-
abetes begin exhibiting high blood glu-
cose levels during pregnancy, accounting 
for the ~ 90% of all pregnancies compli-
cated by diabetes (1). GDM affects around 
the 7% of all pregnancies and, depending 
on the population sample and diagnostic 
criteria, its prevalence may range from 1 
to 14% (2).
Accepted classical risk factors for 
GDM are: previous diagnosis of GDM or 
pre-diabetes, impaired glucose tolerance, 
or impaired fasting glycemia, a family his-
tory revealing a first degree relative with 
type 2 diabetes, maternal age – a woman’s 
risk factor increases as she gets older (es-
pecially for woman over 35 years of age), 
ethnic background (those with higher risk 
factors include African-Americans, Afro-
Caribbeans, Native Americans, Hispanics, 
Pacific Islanders, and people originating 
from south Asia, overweight, obesity or 
severe obesity increases the risk by a fac-
tor 2.1, 3.6 and 8.6, respectively, a previous 
pregnancy which resulted in a child with a 
high birth which resulted in a child with a 
high birth weight (>90th centile, or >4000 g 
( 8 lbs 12.8 oz), previous poor obstetric his-
tory (3, 4). In addition to this, statistic show 
a double risk of GDM in smokers (5). Ba-
bies born from mothers affected by GDM 
are typically at increased risk of macroso-
mia (6, 7, 8). And of additional problems 
such as the development of childhood 
obesity and of type 2 diabetes later in life. 
Women with GDM are at a significantly 
higher risk of developing preeclampsia or 
hypertension after pregnancy compared 
to healthy subjects (9), probably due to 
presence of preexisting common risk fac-
tors for both GDM and hypertension (10). 
Other studies have shown that GDM may 
be also associated to increased blood iron 
storage and transport (11, 12).In addition, 
different studies on the prevalence of uri-
nary tract infections (UTI), symptomatic 
and/or asymptomatic bacteriuria in dif-
ferent populations of female diabetic pa-
tients reported contrasting results, show-
ing that they can be either increased (13); 
or unchanged to this diabetic complication 
compared to non-diabetic subjects (14).
Hence, the aim of this study was (a) to 
furnish a preliminary description of the 
pathophysiological conditions of two se-
lected population of Kosovar women with 
and without GDM, and (b) to evaluate the 
89 Med Arh. 2013 Apr; 67(2): 88-90  • originAl pAper
Gestational Diabetes Mellitus (GDM) in the Republic of Kosovo: a Retrospective Pilot Study.
effects of diabetes on the impairment of 
blood iron physiological control, blood 
pressure and renal functionality status, 
and susceptibility to develop UTI.
2. eXperiMenTAl STUDY 
DeSign AnD MeTHoDS
Patients, pregnant women (n=60) 
were recruited from the Obstetric-Gy-
necologic Clinic of Prishtina (QKUK, 
Republic of Kosovo) during the years 
2010/2012 and divided in two groups on 
the basis of diagnosis: GDM group (n=30) 
and control group (CTR, total n=30 with-
out GDM, of which n=18 had normal clin-
ical pregnancy status and n=12 treated 
for preeclampsia). All women gave de-
livery by Cesarean delivery exception for 
6 patients for which delivery was stimu-
lated by oxitocin administration. Patients 
were followed-up from 2010 to 2012. The 
measurements of blood parameters gly-
caemia, creatinine, albumin, lympho-
cytes, monocytes, granulocytes, white 
blood cells, red blood cells, haemoglo-
bin, Glomerular filtration rate (GFR) was 
estimated using the modification of diet 
in renal disease (MDRD) algorithm [15].
Urine analysis with microscopy epithelial 
cells, leukocytes, bacteria, oxalate crys-
tals and erythrocytes, as well as histolog-
ical examination were carried out using 
standard assay procedures of laboratory 
of Biochemistry of the University Clini-
cal Center of Kosovo (UCCK). The pres-
ence/absence of vaginal infections was 
established using standard microbiolog-
ical protocols in institute of microbiol-
ogy in the University Clinical Center of 
Kosovo (UCCK). Vaginal wet mount was 
observed with microscopy by placing the 
specimen on a glass slide and mixing with 
a salt solution.
Continuous clinical variables were 
compared by two-tailed pairwise Stu-
dent’s t test for independent measure-
ments with Bonferroni’s correction for 
multiple comparisons and discrete vari-
ables by Fisher’s exact test. Computations 
were conducted on original data and on 
log transformed data to reduce the ef-
fect of skewness. Minimal level of signif-
icance of the difference was set at P<0.05. 
The data matrices for computations were 
built with an OpenOffice Calc Spread-
sheet for Linux (v. 3.2.1), and all computa-
tions were done with R-commander GUI 
for R (v. 1.5–6) [16].
3. reSUlTS AnD 
DiSCUSSion
In Table 1 and Table 2 are reported 
means, standard deviations and quintiles 
for the monitored physiological param-
eters (weights of babies, weeks of gesta-
tion at clinical visit, systolic and diastolic 
BP), blood biochemical parameters (cre-
atinine, glucose, albumin, hemoglobin), 
blood cells profile (lymphocytes, mono-
cytes, red blood cells (RBC), white blood 
cells (WBC) and granulocytes), and re-
nal functionality determined in preg-
nant women with and without GDM re-
spectively.
Gestation duration was lower than 
the full term of 40 weeks for normal de-
livery in both groups. The gestation time 
before delivery was 2.7 weeks shorter in 
group II (35.8 ± 2.5 weeks) compared to 
group I (38.5 ± 2.2 weeks, P<0.001). Mean 
values of babies weight, and mothers’ 
systolic and diastolic BP, creatinine, al-
bumin, WBC and granulocytes in both 
groups were within their normal ranges, 
with no significant difference between 
the two groups (P>0.05). However, for 
both groups, women falling into the two 
highest quintiles (IV and V) showed sys-
tolic and diastolic BP higher than ref-
erence values. In both groups, lympho-
cytes and monocytes mean values and 
quintiles were significantly elevated in 
respect to the matched reference values 
for the CTR group (17). Probably resulting 
from the presence of infections in both 
groups (see paragraph 3.2). As expected, 
blood glucose was higher in group I (mean 
± SD: 7.43 ± 2.23 mg/dL vs. 4.33 ± 0.63 
mg/dL; P<0.001), on account of their di-
abetic status. Women in this group had 
also higher RBC (mean±SD: 4.4±0.8 % 
vs. 3.8±0.3 %; P<0.005) and HGB (mean 
± SD: 13.0 ± 3.2 g/dL vs. 11.2 ± 1.4 mg/
dL; P<0.05). Women with GD showed de-
creased renal functionality, as evidenced 
by the significant decrease of their mean 
GFR value in respect to that of women 
with preeclampsia (MDRD-GFR: 92.8 ± 
25.8 g/dL vs. 108.2 ± 38.2 g/dL; P<0.05).
The high concentration of mitochon-
dria in placenta, one of the major sources 
of free radicals in living organism, may be 
a causal/concurrent condition in the de-
velopment of GDM, due to the oxidative 
stress that may be induced by the impair-
ment of their activity. In particular, iron, 
which is abundant in placenta, is one of 
the most important generators of highly 
reactive free radicals in both normal and 
pathological conditions (18). Our findings 
that blood iron, in terms of blood HGB 
and RBC, is significantly elevated in preg-
nant women affected by GDM compared 
with women with preeclampsia (Hb: 13.0 
± 3.2 g/dL vs.11.2 ± 1.4 g/dL; P<.05) are 
in good agreement with those recently re-
ported in a similar study by Afkhami-Ar-
dekani et al. (11). In this study the concen-
trations of serum ferritin, iron, transfer-
rin saturation and HGB, MCV, and MCH 
were significantly higher in Iranian preg-
nant women with GDM (Hb: 13.4 ±1.1 g/
dL vs. 11.8 ± 1.4 g/dL; P<.001), indicating 
a potential association between increased 
iron status and GDM. A few years earlier, 
Table 1. Pregnant women with GD (normal ranges in brackets from ref 17. *P<0.05; ***P<0.005; 
****P<0.001 compared to CTR group. (tab.2). Values exceeding refernces values are in bold. 
Table 2. Control pregnant women (normal ranges in brackets from ref. 17. *P<0.05; ***P<0.005; 
****P<0.001 compared to CTR group. (tab.2). Values exceeding refernces values are in bold.
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Chan and colleagues concluded 
that increased iron storage and 
transport, (e.g. elevated serum 
ferritin), early in gestation are as-
sociated with an increased risk 
of GDM (12). The results of their 
study suggested that this associa-
tion, at least in part, may be medi-
ated by the maternal fat mass and 
obesity. Similar conclusions were 
reported in 2002 by Lao and col-
leagues working on a population 
of Chinese pregnant women (19). 
These authors found that high ma-
ternal hemoglobin (more than 13 
g/dL) at the initial prenatal visit in 
a population of Chinese women 
is an independent risk factor for 
GDM. In another study the same au-
thors found that maternal hepatitis B sur-
face antigen (HBsAg) carriage could ex-
plain in part the association between in-
creased serum ferritin concentration with 
GD, and that the HBsAg carrier status is 
an independent risk factor for GDM (20).
The decrease of renal functionality 
we found in pregnant women affected by 
GDM (115.3±16.0 vs 101.3±18.5 (Table 1 
and Table 2) without significant increase 
of BP, indicated that this loss of renal 
functionality was probably associated to 
a glomerular damage still in an early stage 
of development. By contrast, as shown in 
Figure 1, the loss of renal functionality 
observed in pregnant women with GD 
was paralleled by a highly significant ele-
vation of UTI compared to those affected 
by BP dysfunctions (100% vs. 13.3%, 
P<0.001). These results were in good ac-
cordance with those from previous stud-
ies reporting that mothers affected by 
GDM are at higher risk of complications 
from UTI along with preeclampsia, hy-
pertension, and Cesarean delivery (21). 
In particular, the predisposition to UTI 
in DM and GDM may result from sev-
eral factors. Susceptibility to this kind of 
infections seems to increase with longer 
duration and greater severity of diabetes. 
As different studies have investigated the 
role of UTI in preeclampsia (22, 23, 24, 25, 
26). The role of UTI in GDM is poorly in-
vestigated and understood (27). Only few 
studies have shown that UTI caused by 
different bacteria are common in women 
with GD, and that their growth is proba-
bly due the favorable growth conditions 
induced by high blood and urine glucose. 
The results of the present study support 
this conclusion, as well evidenced by the 
dramatic difference in the UTI prevalence 
found for the pregnant women belonging 
to the GDM group and to the CTR group, 
in which only those in GDM group were 
affected by diabetes (Figure 1).
4. ConClUSionS
The results reported in this study have 
shown that women affected by GDM have, 
apart higher blood glucose, enhanced blood 
iron transport and storage, decreased renal 
performance and higher prevalence of UTI. 
Hence, it can be hypothesized that the strik-
ingly higher prevalence of UTI in GDM may 
originate from the cascade of events sum-
marized in the scheme reported in Figure 
2. The insulin resistance and the increase 
oxidative stress mediated by the impaired 
of iron metabolism associated to pregnancy 
status and further elicited by GDM, leads to 
the enhancement of blood glucose, which 
is known to trigger detrimental processes 
damaging the renal glomerular filtration 
system, which in turn lead to the progres-
sive increase of BP. The consequent rise in 
urine glucose concentration and enhanced 
tissue permeability may then ‘open the way’ 
to the diffusion of microorganisms and 
pathogens into the urinary tract. These 
findings, although limited by the low num-
ber of subjects involved and by to its retro-
spective design, warrant to keep support-
ing the research on appropriate measures 
and methodologies for the prevention, the 
treatment and the management of all the 
different multifaceted aspects of GDM in-
cluding UTI iron intake monitoring, to en-
sure better and safer pregnancy outcomes.
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Figure 1. Results of examination between GDM and CTR 
groups
Figure 2. Prevalence of UTI in GDM
